Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02993068
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:23.989164+00:00
Published At
2026-02-19T00:00:00+00:00
Record Updated At
2026-02-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["BARD1 Gene Mutation", "BRCA1 Gene Mutation", "BRCA2 Gene Mutation", "BRIP1 Gene Mutation", "Estrogen Receptor Negative", "HER2/Neu Negative", "MLH1 Gene Mutation", "MSH2 Gene Mutation", "MSH6 Gene Mutation", "PALB2 Gene Mutation", "PMS2 Gene Mutation", "Progesterone Receptor Negative", "RAD51C Gene Mutation", "RAD51D Gene Mutation", "Triple-Negative Breast Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-19"
protocolSection.identificationModule.nctId
"NCT02993068"
protocolSection.identificationModule.officialTitle
"Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)"
protocolSection.statusModule.overallStatus
"SUSPENDED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • BARD1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • BRCA1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • BRCA2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • BRIP1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • Estrogen Receptor Negative (protocolSection.conditionsModule.conditions)
  • HER2/Neu Negative (protocolSection.conditionsModule.conditions)
  • MLH1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • MSH2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • MSH6 Gene Mutation (protocolSection.conditionsModule.conditions)
  • PALB2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • PMS2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • Progesterone Receptor Negative (protocolSection.conditionsModule.conditions)
  • RAD51C Gene Mutation (protocolSection.conditionsModule.conditions)
  • RAD51D Gene Mutation (protocolSection.conditionsModule.conditions)
  • Triple-Negative Breast Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.